Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
NRIX
$22.73
+0.58%
NRIX
· Nurix Therapeutics, Inc.
$22.73
+0.13 (+0.58%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$2.36B
Shares
103.78M
Volume · Oct 7
1.63M
Avg daily vol (3M)
1.27M
All webcasts
Earnings call · FY2026 Q2
Nurix Therapeutics, Inc. (NRIX) Q2 2026 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue
$9.04M
-79.5% YoY
Diluted EPS
-$0.81
Net income
-$89.53M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 9, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Jul 9, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Jun 8, 2026 · complete as-filed document